The Feasibility of Pertussis Immunization in a Canadian Emergency Department
1 other identifier
interventional
644
1 country
1
Brief Summary
Randomized controlled trial of 2 strategies to provide adults with the Tdap vaccine to patients presenting to the emergency department. Rates of vaccination as well as effects on department efficiency will be measured.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 10, 2017
CompletedFirst Submitted
Initial submission to the registry
September 25, 2017
CompletedFirst Posted
Study publicly available on registry
October 6, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2017
CompletedJanuary 26, 2018
January 1, 2018
5 months
September 25, 2017
January 24, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rate of immunization
Rate of patients receiving Tdap vaccine
One day
Secondary Outcomes (7)
Length of Stay
One day
Left with out being seen rate
One day
Time to physician
One day
Patient refusals
One day
Nursing satisfaction
One day
- +2 more secondary outcomes
Study Arms (2)
Emergency Department vaccination group
EXPERIMENTALPertussis (Tdap) vaccine offered/administered in the Emergency Department
Public Health referral group
EXPERIMENTALPublic Health referral for Pertussis (Tdap) vaccine administration offered
Interventions
Randomized controlled trial of 2 strategies to provide adults with the Tdap vaccine
Eligibility Criteria
You may qualify if:
- Adults age 18 and above
- Have not received Tdap vaccine as an adult (age 18 and above) or have not received Tdap vaccine within 10 years, or unsure of vaccination status
You may not qualify if:
- Acute significant illness (Canadian Triage and Acuity Scale = 1)
- Deemed "in too much distress" by triage nurse
- Acute Febrile illness
- Allergy to vaccine or vaccine components
- Pts presenting for wound care (are normally given the vaccine as part of wound care)
- Pregnancy \< 26 weeks
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Prince Edward Islandlead
- The Queen Elizabeth Hospitalcollaborator
Study Sites (1)
Queen Elizabeth Hospital
Charlottetown, Prince Edward Island, PO Box 6600, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Aaron Sibley, MD
University of Prince Edward Island
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 25, 2017
First Posted
October 6, 2017
Study Start
July 10, 2017
Primary Completion
December 20, 2017
Study Completion
December 20, 2017
Last Updated
January 26, 2018
Record last verified: 2018-01
Data Sharing
- IPD Sharing
- Will not share